Carotid Artery Stenting With Cilostazol Addition for Restenosis (CAS-CARE)
Effect of Cilostazol on In-stent Restenosis After Carotid Artery Stenting; Multi-center, Prospective, Randomized, Open-label Blind-endpoint Trial
Sponsor: Chiba University
A NA clinical study on In-stent Restenosis After Carotid Artery Stenting, this trial is completed. The trial is conducted by Chiba University and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Nov 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed · Phase: PHASE4 → NA
-
Jun 2018 — Nov 2019 [monthly]
Active Not Recruiting PHASE4
▶ Show 3 earlier versions
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Feb 2017 — Mar 2018 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Dec 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chiba University
- Foundation for Biomedical Research and Innovation
- Fukuoka University
- Kobe City General Hospital
- Kobe University
- Kyoto University
- Mie University
- Nagasaki University
- Nagoya University
- Okayama University
- Osaka University
- Wakayama Medical University
- Yamaguchi University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .